Pharmacopsychiatry 2010; 43(5): 179-183
DOI: 10.1055/s-0030-1249096
Original Paper

© Georg Thieme Verlag KG Stuttgart · New York

Transitions from General Practitioner to Psychiatrist Care (or vice versa) during a First Antidepressant Treatment Episode

H. Gardarsdottir1 , 2 , A. C. G. Egberts1 , 2 , E. R. Heerdink1 , 2
  • 1Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands
  • 2Department of Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, The Netherlands
Further Information

Publication History

received 03.08.2009 revised 13.01.2010

accepted 22.01.2010

Publication Date:
18 May 2010 (online)

Preview

Abstract

Introduction: The aim of this study was to investigate how frequently patients transit from general practitioner (GP) to psychiatrist care and vice versa during a first antidepressant episode and antidepressant treatment changes associated with those transitions.

Method: Antidepressant episodes were constructed for patients (≥18 years) initiating SSRI use in 2000 (N=10 158). Transition in care within a first treatment episode was investigated. Changes in antidepressant treatment were compared between transiting and non-transiting patients.

Results: 6.0% of patients who initiate SSRI use in GP practice transited to psychiatrist care, whereas 39.1% of those initiating use in psychiatrist care transited to GP care. Patients transiting from GP to psychiatrist care were more likely to switch to other antidepressants (RR=6.16, 95% CI: 4.90, 7.75) or to other doses (RR=4.48, 95% CI: 3.76, 5.34) than non-transiting patients. No significant differences in antidepressant treatment were found for patients transiting from psychiatric to GP care.

Discussion: Approximately 9% of SSRI initiators transit in care. Transitions from GP to psychiatric care lead to antidepressant treatment changes and could potentially be used in observational studies as a disease severity indicator.

References

Correspondence

Dr. E. R. Heerdink

Division of Pharmacoepidemiology

and Pharmacotherapy

Utrecht Institute for

Pharmaceutical Sciences

Faculty of Science

Utrecht University

PO Box 80.082

3508 TB Utrecht

The Netherlands

Phone: + 31-30-2537324

Fax: + 31-30-2539166

Email: E.R.Heerdink@uu.nl